Barclays’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Barclays’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,013	Closed	-$28.8K	–	5477
2023 Q4	$28.8K	Buy	24,013 +21,572	+884%	+$23.3K	﹤0.01%	4855
2023 Q3	$2.1K	Sell	2,441 -901	-27%	-$987	﹤0.01%	4451
2023 Q2	$4.01K	Sell	3,342 -22,096	-87%	-$111K	﹤0.01%	4291
2023 Q1	$222K	Buy	+25,438	New	+$235K	﹤0.01%	3728
2022 Q2	–	Sell	-2,616	Closed	-$13K	–	5361
2022 Q1	$13K	Buy	+2,616	New	+$21K	﹤0.01%	4557

Barclays's RAIN Position: Q1 2024 in Review

Barclays sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 24,013 shares — an estimated $28.8K sold.

Barclays first reported a position in RAIN in Q1 2022 and held it in 5 quarters. The position peaked at $222K in Q1 2023. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Barclays reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Barclays sold 24,013 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $28.8K.
Barclays first reported a position in Rain Oncology Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Barclays's Rain Oncology Inc. Common Stock position peaked at $222K in Q1 2023.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.